Home / Acne / Topical erythromycin and zinc therapy for acne.

Topical erythromycin and zinc therapy for acne.

PMID: 2138176  

A double-blind, 12-week study was undertaken to determine the safety and efficacy of a formulation of 4% erythromycin plus 1.2% zinc acetate compared with its vehicle. The study was continued for 40 weeks after the 12-week double-blind phase by switching vehicle-treated patients to active treatment and continuing to give patients treated with active drug the same treatment. Seventy-three female patients started the study; 39 completed 1 full year of study. In the first 12 weeks statistically significant differences were noted in the efficacy of the erythromycin-zinc compared with vehicle for acne severity grades (global assessment) and for papule, pustule, and comedo counts. After crossover, the vehicle-treated group receiving active therapy duplicated the improvement of the group initially treated with erythromycin-zinc. No clinical problems with superinfection or secondary infection occurred during 1 year of treatment in 39 patients.

Schachner L,  Eaglstein W,  Kittles C,  Mertz P


Check Also

Indicators of phagocytosis in women with acne during comprehensive treatment that included immunotherapy and probiotics.

PMID: 29602922   Introduction: Acne is one of the most common dermatological diseases. It may have …

Leave a Reply

Your email address will not be published. Required fields are marked *